Adverse Events

0

Removing Bias from HEOR: Standardizing the Costs of Adverse Events

Posted on by Jim Davis

What are the total costs of prescribing a particular drug? At its core, all health economics and outcomes research (HEOR) studies are designed to answer this fundamental question. And it is this answer that helps to remove barriers to market… Continue Reading →

0

21st Century Cures and Off-Label Promotion Benefit HEOR and Drug Safety

Posted on by Jim Davis

As my writing for the AdverseEvents Blog can attest, I’m in favor of data transparency. In my view, no organization should have monopolistic control over important information that limits the ability for healthcare decision makers to perform unbiased, objective comparative… Continue Reading →